NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
No Result
View All Result
Home ALL Healthcare

ABBOTT RECEIVES FDA CLEARANCE FOR ITS IMAGING TECHNOLOGY USING ARTIFICIAL INTELLIGENCE FOR VESSELS IN THE HEART

by Ed Johnson
August 4, 2021
A A

– Ultreon™ 1.0 Software, the first-of-its-kind imaging software, merges optical coherence tomography with the power of automation using Artificial Intelligence

– The new intuitive interface provides step-by-step guidance to enhance ease of use

– When combined with Abbott’s Dragonfly OpStar™ imaging catheter and PressureWire X™, the platform provides physicians with a comprehensive set of tools to provide better patient care

Abbott (NYSE: ABT) today announced it has received U.S. Food and Drug Administration (FDA) clearance for its latest optical coherence tomography (OCT) imaging platform powered by the company’s new Ultreon Software. This innovative imaging software combines OCT with artificial intelligence (AI) to provide physicians an enhanced, comprehensive view of coronary blood flow and blockages to assist physician decision-making and provide the best pathway for treatment.

U.S. clearance follows the recently attained CE Mark in Europe, providing broader access to the latest OCT imaging platform for interventional cardiologists seeking to utilize the latest in AI-powered technology. Ultreon Software integrates with Abbott’s new Dragonfly OpStar imaging catheter and PressureWire X guidewire to provide physicians access to a broad set of tools to assess coronary blood flow and blockages and improve treatment planning for patients.   

“Abbott’s new Ultreon Software for OCT provides an automated, comprehensive view of the artery that facilitates physician decision-making,” said Ziad Ali, M.D.D.Phil, director of the DeMatteis Cardiovascular Institute at St. Francis Hospital and Heart Center in New York. “Ultreon Software guides stents to be placed with precision. These types of innovative technologies are instrumental in providing the best care for our patients.”

Earlier this year, an annual study by Abbott titled Beyond Intervention revealed that physicians view forward-thinking and innovative technologies as critical components to providing the best patient care. According to the research, 83.2% of physicians agreed that advances in diagnostic and treatment technologies, such as OCT, have translated to tangible improvements in patient care.1

“As cardiologists continue to adopt OCT and move away from traditional imaging methods such as angiography, emerging technologies are pivotal to determine the best course of patient care,” said Nick West, M.D., chief medical officer and divisional vice president of global medical affairs at Abbott’s vascular business. “AI enables Ultreon Software to automatically detect calcium and vessel diameters allowing doctors to put stents exactly where they are needed.”

The launch of Ultreon Software for OCT in the United States demonstrates Abbott’s commitment to continual innovation in the global vascular community with the latest medical devices and technologies. For example, recent data shows that when OCT is paired with Abbott’s MLD MAX, a new workflow that helps guide and optimize stenting decisions, physicians have altered their treatment strategy in treating 88% of coronary artery blockages.2 Abbott’s latest technologies play a vital role in improving cardiovascular patient care and achieving optimal outcomes during and after intervention. For U.S. important safety information on Ultreon, visit: https://abbo.tt/3qAujzc

Abbott showcased Ultreon Software for the first time at EuroPCR 2021 and recently received approval in Japan.

Tags: < Innovation
ShareTweetShareSend

Related Industries

Healthcare

Medtronic recommends rejection of below-market mini-tender offer by TRC Capital Investment Corporation

January 26, 2023
Healthcare

Johnson & Johnson Reports Q4 and Full-Year 2022 Results

January 25, 2023
Healthcare

Pfizer Expands ‘An Accord for a Healthier World’ Product Offering to Include Full Portfolio for Greater Benefit to 1.2 Billion People in 45 Lower-Income Countries

January 18, 2023
Healthcare

AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators against Oncology and Immunology Targets

January 11, 2023
Healthcare

Baxter Announces Strategic Actions to Enhance Operational Effectiveness, Accelerate Innovation for Patients and Drive Value for Shareholders

January 7, 2023
Healthcare

Michelle Quinn Named Acting General Counsel for BD

January 7, 2023

ABB sells Power Conversion division to AcBel Polytech Inc. for $505 million

January 21, 2023

...

Honeywell Identifies Top Building Technology Trends For 2023

January 11, 2023

...

chevron finalizes acquisition of beyond6 CNG fueling network

January 4, 2023

...

Thermo Fisher Scientific Completes Acquisition of The Binding Site Group

January 4, 2023

...

Quadric and ams OSRAM collaborate to bring intelligent image sensors demonstration to CES

January 6, 2023

...

Dow named one of America’s most JUST Companies for the fourth year by JUST Capital

Dow named one of America’s most JUST Companies for the fourth year by JUST Capital

January 11, 2023

...

BYD Partners with NVIDIA to Bring GeForce NOW Cloud Gaming to New Energy Vehicles

January 5, 2023

...

IHG Hotels & Resorts’ voco hotels Enters 2023 with Strong Growth Momentum

January 19, 2023

...

Randstad announces new leaders for Asia Pacific, North America and Technologies business.

January 6, 2023

...

NORTH AMERICAN BUSINESS (www.na-biz.com) is a leading source of business and corporate news, information, industry trends, market updates and insights across a broad spectrum of industries in North America and worldwide.

INDUSTRIES

  • Aero
  • Agriculture
  • ALL
  • Automotive
  • Business Service
  • Chemical
  • Construction
  • Construction Materials
  • Consumer
  • Education
  • Energy
  • Entertainment
  • Environmental
  • F&B
  • Financial
  • Healthcare
  • Hospitality
  • Industrial
  • IT
  • IT Hardware
  • Logistic
  • Metal & Mining
  • Packaging & Paper
  • Rail
  • Real Estate
  • Telecom

CONTACT US

EDITORIAL:     editor#na-biz.com

PARTNERSHIP:     biz#na-biz.com

HUMAN RESOURCE:     hr#na-biz.com

* (replace # with @)

  • Official Site

Copyright © NA-BIZ.COM All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © NA-BIZ.COM All rights reserved.